Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 13Infertility 4Leiomyoma 2Anovulation 2hCG 1Uterine Anomalies 1Salpingitis 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Ovarian Hyperstimulation Syndrome 1Infertility, Female 1Gonadal Disorders 1Endometritis 1Endometriosis 1Endocrine System Diseases 1Breast Neoplasms 1

Interventions

Metformin 10Clomiphene 10Inositol 3Medroxyprogesterone Acetate 2Letrozole 2Glycoprotein Hormones, alpha Subunit 2Folic Acid 2Chorionic Gonadotropin 2salicylsalicylic acid 1maltodextrin 1Vitamin D 1Sodium Salicylate 1Raloxifene Hydrochloride 1Progestins 1Progesterone 1Nimodipine 1Lactalbumin 1Inulin 1Flutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Anovulation × Chorionic Gonadotropin × Clear all
NCT01653743 2016-01-07

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
81 enrolled 11 charts

Anovulation, Polycystic Ovary Syndrome

NCT02551367 2015-09-16

LVCCFOROI

Ain Shams Maternity Hospital

Phase 2 Unknown
110 enrolled

Anovulation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡